Clinical effect of spleen aminopeptide on improving liver function damage and immune function in children with infant hepatitis syndrome

Table 2 Comparison of liver function levels between the two groups (mean ± SD)

Group	TBIL (μmol/L)		DBIL (μmol/L)		Serum alanine transferase (U/L)
	Before therapy	After treatment	Before therapy	After treatment	Before therapy	After treatment
Control group (50)	172.34 ± 32.18	75.78 ± 9.32	50.34 ± 12.25	32.51 ± 9.82	79.93 ± 19.27	69.85 ± 7.04
Therapy group (50)	173.32 ± 29.63	53.62 ± 8.66	49.36 ± 13.64	16.87 ± 3.81	73.94 ± 21.23	43.37 ± 8.30
t	-0.158	12.317	0.378	10.499	1.477	17.204
P value	0.874	0.000	0.706	0.000	0.143	0.000

DBIL: Direct bilirubin; TBIL: Total bilirubin.